Guiding Principles on Ethics in Digital Health Produced During a Seminar at Stanford Libraries
Proteus Digital Health and more than 30 representatives from technology, pharmaceutical, healthcare, public policy, law and bioethics convene at Stanford to address the responsibility around management of personal data.
February 21, 2019 —Stanford, Calif.—Stanford Libraries and its partners today unveiled Guiding Principles on Ethics in Digital Healthresulting from a multiday seminar that brought together industry, academic and nonprofit leaders to address the growing concern about management and use of personal health data by digital health organizations.
The document begins to define 10 principles for digital health entities to ensure the ethical use of their products and services and the information they collect and generate. These principles aim to help digital health organizations navigate potential conflicts between individuals’ need for privacy and society’s need for protecting public health.
“Libraries have long served as staunch advocates of protecting personal data,” said Michael A. Keller, Stanford’s university librarian and vice provost for teaching and learning. “An academic library’s online and offline environments are designed to pique conversation and debate, and given the exponential rate of developments occurring in the digital health space, we offered to initiate the conversation and report out on results of the seminar.”
In July and November 2018 participants discussed and deliberated what consumers should expect from a digital health organization and what obligations that organization has to consumers and to society. The resulting Guiding Principles represent the shared views of over 30 participants:
- The products of digital health companies should always work in patients’ interests.
- Sharing digital health information should always be to improve a patient’s outcomes and those of others.
- “Do no harm” should apply to the use and sharing of all digital health information.
- Patients should never be forced to use digital health products against their wishes.
- Patients should be able to decide whether their information is shared, and to know how a digital health company uses information to generate revenues.
- Digital health information should be accurate.
- Digital health information should be protected with strong security tools.
- Security violations should be reported promptly along with what is being done to fix them.
- Digital health products should allow patients to be more connected to their care givers.
- Patients should be actively engaged in the community that is shaping digital health products.
Additional details for each of the 10 principles are available online for downloadand broader sharing.
“The range of senior level participants in the meetings and the quality of contributions give me confidence that a set of leaders are emerging who take ethical considerations associated with management of personal data very seriously,” said Keller, who convened the Digital Health Ethics Seminar and is planning to launch an entire series of conversationswith leaders from various industries to discuss ethical implications in their respective verticals. Future seminars under consideration are ethics in communications, transportation, and agriculture and food supply.
According to former Surgeon General and Proteus Board Member Regina Benjamin M.D., who also participated in the Seminar, “the Guiding Principles on Ethics in Digital Health is a positive step towards ensuring organizations take seriously their duty to care for personal data and do no harm. It is also very valuable to set expectations for patients, so they are aware of the potential risks of using a digital health product.”
Stanford Librarieshave been at the forefront of development of digital technologies, tools and information services. The Guiding Principles for Ethics in Digital Health and all forthcoming documentation from the other seminars in the series will eventually be deposited into the Stanford Digital Repository and become part of the university’s discovery environment. “Our intent is to not just make these principles as accessible as possible, but to preserve them as a snapshot in time for researchers and industry leaders invested in this topic,” said Keller.
“This is only a first step at addressing the ethical questions looming in digital health. We must start somewhere, so let these principles serve as the conversation starter,” said Keller. “We want this first set of ten statements to spur conversations in board rooms, classrooms and community centers around the country and ultimately be refined and adopted widely.”
To download the Guiding Principles, learn more about the participants and the seminar visit https://library.stanford.edu/digitalhealthethics.
ABOUT STANFORD LIBRARIES
Stanford Libraries is considered a leading institution for the development of digital technologies, tools and services impacting libraries and archives worldwide. With notable developments in digital technology and its use to increase speed-to-knowledge, Stanford Libraries has become a destination for many of the world's leaders of knowledge curation. With a collection of over 12 million items, Stanford Libraries has created a dynamic discovery environment that powers research, teaching and learning at Stanford and beyond. https://library.stanford.edu| @StanfordLibs
About Proteus Digital Health®
Proteus Digital Health® is enabling a new category of pharmaceuticals: Digital Medicines. These include widely used drugs, formulated so they communicate when they have been ingested; a wearable patch that detects medicines and captures physiologic response; mobile applications to support patient self-care and physician decision-making; and data analytics to serve the needs of health system managers. The company has more than 540 issued patents that protect this enabling technology, and regulatory clearances in the U.S., European Union and China.
Proteus Digital Health is privately held by investors that include Carlyle, Essex Woodlands, Kaiser Permanente®, Medtronic®, Novartis®, Otsuka, and ON Semiconductor®. Further information is available at: www.proteus.com. Connect with us on Twitter @ProteusDH.
Gabrielle Karampelas | 650-497-4414